Norethindrone

Drug Usage Statistics, United States, 2006 - 2016

Number of Prescriptions Over Time (2006 - 2016)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2006 258  18
2007 251  7
2008 264  13
2009 295  31
2010 299  4
2011 264  35
Year Rank Change
2012 222  42
2013 229  7
2014 250  21
2015 265  15
2016 265 0

Patient Out-Of-Pocket Cost Over Time (2006 - 2016)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2016)
Levonorgestrel 2,364,900
Medroxyprogesterone Acetate 1,850,808
Norethindrone (this drug) 1,666,057

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Camila
  • Errin
  • Heather
  • Incassia
  • Jencycla
  • Micronor
  • Nor-QD
  • Norlutin
  • Aygestin
  • Norlutate
Generic Drug Synonyms and Salts
  • Norethindrone Acetate
  • Norethindrone

FDA Approval Information

Established Pharmacologic Class (EPC): Progestin
Initial FDA approval date: Prior to January 1, 1982
First FDA applicant: Discn
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2006-2016. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 19.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top
Top